Cargando…

Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019

BACKGROUND: Pancreatic cancer patients were particularly predisposed to develop Escherichia coli (E. coli) bloodstream infection (BSI); however, little information is currently available. We set out to find E. coli BSI's risk factors in pancreatic cancer to provide valuable experience. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Changsen, Zhang, Xiuse, Yang, Dong, Li, Ding, Feng, Honglei, Li, Yueguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942694/ https://www.ncbi.nlm.nih.gov/pubmed/35340919 http://dx.doi.org/10.1155/2022/1338188

Ejemplares similares

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli From Bloodstream Infection in Shanghai, China, 2016–2019
por: Xiao, Shuzhen, et al.
Publicado: (2022)

Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study
por: Zhang, Qing, et al.
Publicado: (2019)

Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes
por: Tu, Bo, et al.
Publicado: (2017)

Escherichia coli bloodstream infection preceding the diagnosis of rectal carcinoma
por: Thoma, Reto, et al.
Publicado: (2018)

Population-Based Incidence and Characteristics of Adult Escherichia coli Bloodstream Infection in Queensland, Australia, From 2000 to 2019
por: Ling, Weiping, et al.
Publicado: (2023)

Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanxi, China
por: Zhang, Yanjun, et al.
Publicado: (2021)

A TTP-incorporated scoring model for predicting mortality of solid tumor patients with bloodstream infection caused by Escherichia coli
por: Zhang, Qing, et al.
Publicado: (2021)

Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections
por: Kim, Yong Chan, et al.
Publicado: (2023)

The Characteristics of Extended-Spectrum β-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream Infection
por: Li, Rongrong, et al.
Publicado: (2023)

Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics
por: Daga, Ana Paula, et al.
Publicado: (2019)

Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005 – 2011
por: Williamson, Deborah A, et al.
Publicado: (2013)

Homologous Escherichia coli Identified in Cerebrospinal Fluid and Bloodstream
por: Shi, Qingmiao, et al.
Publicado: (2021)

Analysis of early-onset bloodstream infection due to Escherichia coli infection in premature babies
por: Chen, I-Lun, et al.
Publicado: (2017)

Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection
por: Duan, Jinyan, et al.
Publicado: (2016)

Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in Korea
por: Kim, Young Ah, et al.
Publicado: (2017)

The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans
por: Burgaya, Judit, et al.
Publicado: (2023)

Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study
por: Tamma, Pranita D, et al.
Publicado: (2022)

Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time Periods
por: Pitout, Johann D. D.
Publicado: (2021)

Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study
por: MacKinnon, Melissa C., et al.
Publicado: (2021)

Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China
por: Wang, Su, et al.
Publicado: (2016)

Complete Genome Sequences of Four Escherichia coli ST95 Isolates from Bloodstream Infections
por: Stephens, Craig M., et al.
Publicado: (2015)

Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection
por: Mac Aogáin, Micheál, et al.
Publicado: (2016)

A prospective study of Escherichia coli bloodstream infection among adolescents and adults in northern Tanzania
por: Madut, Deng B, et al.
Publicado: (2020)

Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing
por: Paramita, Rafika Indah, et al.
Publicado: (2020)

Bloodstream infection by mcr-1-harboring Escherichia coli in a cancer patient in southern Brazil
por: Lorenzoni, Vinícius Victor, et al.
Publicado: (2018)

Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections
por: Shropshire, William C., et al.
Publicado: (2023)

210. Evaluating the Costs of Escherichia coli Bloodstream Infections: A Population-Based Cohort Study
por: King, Teagan, et al.
Publicado: (2023)

Characterization of NDM-5-Producing Escherichia coli Strains Isolated from Pediatric Patients with Bloodstream Infections in a Chinese Hospital
por: Huang, Lili, et al.
Publicado: (2023)

High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses
por: Cui, Ranliang, et al.
Publicado: (2022)

Characteristics of Escherichia coli Urine Isolates and Risk Factors for Secondary Bloodstream Infections in Patients with Urinary Tract Infections
por: Choi, Hyeon Jin, et al.
Publicado: (2022)

Epidemiology and molecular characterization of mcr-1 in Escherichia coli recovered from patients with bloodstream infections in Changsha, central China
por: Zhong, Yi-Ming, et al.
Publicado: (2019)

Molecular Characteristics of Escherichia coli Causing Bloodstream Infections During 2010–2015 in a Tertiary Hospital, Shanghai, China
por: Li, Dan, et al.
Publicado: (2021)

Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible
por: Baker, Thomas M, et al.
Publicado: (2018)

Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
por: Wang, Yuan, et al.
Publicado: (2020)

Antibiotic Resistance Profile and Diversity of Subtypes Genes in Escherichia coli Causing Bloodstream Infection in Northern Vietnam
por: Hung, Pham Ngoc, et al.
Publicado: (2019)

Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis
por: Chen, Wen-Chi, et al.
Publicado: (2021)

Effect of temperature on Escherichia coli bloodstream infection in a nationwide population-based study of incidence and resistance
por: Feldman, Sarah F., et al.
Publicado: (2022)

Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis
por: Vance, Mary Kathryn, et al.
Publicado: (2023)

The rising tide of bloodstream infections with Actinomyces species: bimicrobial infection with Actinomyces odontolyticus and Escherichia coli in an intravenous drug user
por: Weiand, Daniel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3elo7bridh0fbot259pogic2pv